Raymond James Financial Services Advisors, Inc. Co Diagnostics, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 16, 2024	BUY	$1.0 - $1.5 $7,000 - $10,500	7,000 Added 57.14%	19,251 $25,000
Q3 2023 Oct 24, 2023	SELL	$1.03 - $1.85 $287 - $516	-279 Reduced 2.23%	12,251 $12,000
Q2 2023 Jul 25, 2023	SELL	$1.04 - $1.64 $3,234 - $5,100	-3,110 Reduced 19.88%	12,530 $13,000
Q1 2023 Apr 14, 2023	BUY	$1.39 - $3.24 $2,502 - $5,832	1,800 Added 13.01%	15,640 $23,000
Q4 2022 Feb 08, 2023	SELL	$2.32 - $3.68 $4,412 - $6,999	-1,902 Reduced 12.08%	13,840 $34,000
Q3 2022 Oct 25, 2022	SELL	$2.87 - $7.01 $2,548 - $6,224	-888 Reduced 5.34%	15,742 $51,000
Q2 2022 Aug 12, 2022	BUY	$3.76 - $6.29 $11,234 - $18,794	2,988 Added 21.9%	16,630 $93,000
Q1 2022 May 11, 2022	BUY	$5.03 - $9.61 $3,666 - $7,005	729 Added 5.65%	13,642 $84,000
Q4 2021 Feb 08, 2022	BUY	$8.12 - $10.37 $7,713 - $9,851	950 Added 7.94%	12,913 $115,000
Q3 2021 Nov 02, 2021	BUY	$7.48 - $11.38 $89,483 - $136,138	11,963 New	11,963 $116,000

Others Institutions Holding CODX

# of Institutions

Shares Held

4.3M

Call Options Held

48.2K

Put Options Held

53.3K

Vanguard Group Inc Valley Forge, PA

1.78M
Shares

$1.89 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

568K
Shares

$601,785
0.0% of portfolio
Black Rock Inc. New York, NY

502K
Shares

$532,146
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

321K
Shares

$340,551
0.0% of portfolio
Bridgeway Capital Management, LLC Houston, TX

273K
Shares

$289,274
0.01% of portfolio

View Full List

About Co-Diagnostics, Inc.

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $35.8M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

More about CODX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account